Sitemap

• Patients

  • Overview
  • Conditions
    • CNS & Epilepsy
      • Epilepsy
      • ADHD
      • Fibromyalgia
      • Memory problems
      • Migraine
      • Multiple Sclerosis
      • Narcolepsy
      • Neuropathic pain
      • Parkinson's disease
      • Restless Legs Syndrome (RLS)
    • Immunology and inflammation, including allergy and respiratory diseases
      • Allergies
      • Anaphylaxis
      • Asthma
      • Crohn's disease
      • Osteoarthritis
      • Psoriasis
      • Respiratory disorders
      • Rheumatoid arthritis
      • Systemic lupus (SLE)
    • Oncology (cancer)
      • Lung cancer
      • Non-Hodgkin's lymphoma
    • More conditions
      • Bladder disorders
      • Coronary heart disease
      • Digestive disorders
      • Erectile dysfunction
      • Hypertension
      • Iron deficiency
      • Osteoporosis
      • Peripheral arterial occlusive disease
  • Testimonials
    • Allergy
      • Rita Hayward's family
    • Crohn's disease
      • Barbara
      • Craig
      • Miranda
      • Ally
    • Epilepsy
      • Bryan Griffin
      • Michele Walz
      • Heather Overton
    • Parkinson's disease
      • Living with early Parkinson's Disease
      • Living with late Parkinson's Disease
    • Rheumatoid arthritis
      • Alice Peterson
  • Clinical trials
    • About clinical trials
      • FAQ
      • Phase I
      • Phase II
      • Phase III
      • Phase IV
    • UCB policy
    • Trial information search
    • Trial results search
  • Patient Programmes
    • Canine Assistants programme
    • UK Patients & Charitable Organisations
  • Links
    • ADHD
    • Allergies
    • Bladder disorders
    • Crohn's disease
    • Epilepsy
    • Narcolepsy
    • Parkinson's disease
    • Rheumatoid arthritis
  • Contact

• Partners

  • Overview
  • Business Development
    • Partnering
    • Areas of interest
    • Strategic partners
    • Case studies
    • Business Development
  • Suppliers
    • Suppliers' conditions
    • UCB Purchasing

• Investors

  • Overview
  • UCB in brief
    • Company overview
    • R&D Pipeline
    • Fact Sheet
    • Strategy
    • Acquisition of Schwarz Pharma
  • Shares
    • Share price information
      • Investment calculator
      • Share price look-up
      • Share Price Information (HTML)
    • Shareholder structure
    • Capital and shares
    • Warrants
    • Dividends
    • Analyst Coverage
    • Analyst Consensus
  • Financials
    • Key Financial Data
    • Outlook
    • Annual Reports
      • Celltech
      • Schwarz Pharma
  • News
    • UCB Archive
    • Schwarz Pharma archive
  • Presentations
  • Calendar
    • Shareholders' meeting 2008
      • To be elected
    • Shareholders' meeting 2007
      • Agenda of the General Meeting of Shareholders
      • Blockage of shares and authorisation
      • Procedure
      • Procedure for calling meetings
      • Venue and date
    • Shareholders' meeting 2006
    • Shareholders' meeting 2005
    • Shareholders' meeting 2004
    • Shareholders' meeting 2003
  • Corporate Governance
    • Charter
    • Board of Directors
    • Board Committees
    • Executive Committee
    • External Audit
    • Articles of Association
    • Conduct & Ethics
    • Insider Trading
    • Compliance Program

• Job Seekers

  • Overview
  • Our company
  • Our culture and people
  • Your career
    • Leadership and personal development
    • Compensation and company benefits
    • Striking the right work-life balance
    • MBA Career Pathway
      • Applying for MBA programme
    • Traineeships
      • United Kingdom
      • Belgium
    • Quick links
      • FAQ
      • Job alert
  • Applying to UCB
    • Australia
    • Belgium
      • in French
      • in Dutch
    • Bulgaria
    • China and Hong Kong
    • Czech Republic
    • Denmark
    • France
    • Germany
      • Germany - REXX
    • Greece
    • Hungary
    • India
    • Ireland
    • Luxembourg
    • Malaysia & Singapore
    • Mexico
    • Netherlands
    • Norway
    • Poland
    • Sweden
    • Switzerland
    • Taiwan
    • Thailand
    • UK
    • US

• About UCB

  • Overview
  • Vision
  • Strategy
  • Track record
  • Management
  • Facts and figures
    • Company
    • Key strengths
    • Financials
    • Sales
    • Products
    • Pipeline
    • Research & Development
    • Partners
    • Management
    • History
  • CSR
    • Citizenship
    • Health, Safety and Environment
      • Policy
      • Strategy
      • Management System
      • Performance score card
      • Programmes for 2008
  • Info UCB Employees

• Products

  • Overview
  • Contact
  • Product list
    • CNS & Epilepsy
      • Keppra®
      • Neupro® (SP)
      • Equasym XL™ / Metadate CD™
      • Nootropil®
      • Xyrem®
    • Immunology and inflammation, including allergy and respiratory diseases
      • Cimzia®
      • Xyzal®
      • Zyrtec®
      • Tussionex™
      • Lortab™
      • Innovair®
    • More products
      • BUP-4™
      • Deponit® (SP)
      • Edex®/ Viridal® (SP)
      • Elantan® Long (SP)
      • Ferro Sanol Duodenal™ (SP)
      • Ferro Sanol Gyn™ (SP)
      • Isoket® (SP)
      • Nipruss® (SP)
      • Perlinganit® Solution (SP)
      • Prostavasin® (SP)
      • Somatostatin-ucb™
      • Stogar®
      • Uniretic™/Femipres Plus™/Perdix Plus™ (SP)
      • Univasc™ /Femipres™ / Perdix™ (SP)
  • Product Finder
    • Products - Europe
    • Products - Japan
    • Products - Other Regions

• R & D

  • Overview
  • R&D pipeline
    • UCB's new development pipeline
      • brivaracetam
      • CDP323
      • CDP791
      • Cimzia®
      • CMC544
      • Epratuzumab
      • Fesoterodine
      • Keppra ® XR
      • Neupro®
      • Rotigotine
      • Sclerostin antibody
      • VIMPAT™
      • Xyrem®
    • UCB's late stage research pipeline
    • Therapeutic areas
      • CNS
      • Inflammation
      • Oncology
      • Others
  • Science & technologies
    • Innovative and proprietary science and technologies
      • UCB SLAM
      • Antibodies
      • Gene-to-drug
      • A2Hit™
      • Hit Discovery
      • CADD
      • Chromatography
      • SV2A
      • Genomics
    • Innovation in development
      • MIKADO
    • IP strategy
  • Info centre
    • Protein Science Forum 2008
    • Protein Kinase Inhibitor Chart
    • Drug development process
    • How drugs are named
    • NCE & NBE drug discovery overview
    • Facts & figures
    • UCB periodic table
    • UCB's definition of severe diseases
    • R&D Brochure
  • Clinical trials
  • Partnerships
  • People
    • Scientific Advisory Board
      • Prof Sir Tom Blundell
      • Prof Robert B Darnell
      • Prof George E Griffin
      • Dr Francis J T Fildes
      • Dr John M McCall
    • R&D Executive
      • Dr Melanie Lee - Executive Vice President R&D
      • Dr Neil Weir - Senior Vice President Global Research
      • Dr Leah Lipsich, Vice President Global Non-Clinical Developmental Sciences
      • Prof Dr Iris Loew-Friedrich, Senior Vice-President Global Development
      • Patty Fritz - Vice President Global Regulatory Affairs
  • Glossary
  • Contact

• UCB Worldwide

  • Overview
  • Headquarters
  • Australia & New Zealand
  • Austria
  • Belgium & Luxemburg
  • Bulgaria
  • Canada
  • China
  • Czech Republic
  • Denmark
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • India
  • Italy
  • Japan
  • Kazachstan
  • Korea
  • Malaysia
  • Mexico
  • Middle East
  • Norway
  • Pakistan
  • Poland
  • Portugal
  • Romania
  • Russia (+CIS)
  • Singapore
  • Slovak Republic
  • Spain
  • Sweden
  • Switzerland
  • Taiwan
  • Thailand
  • The Netherlands
  • The Philippines
  • Turkey
  • Ukraine
  • United Kingdom
  • U.S.A.
  • Vietnam

• News

  • Overview
  • Press Contacts
  • Media Centre
    • Epilepsy Media Centre
      • Epilepsy Resources
        • Epilepsy Fact Sheets
        • UCB in Epilepsy
        • Epilepsy Awareness Initiatives
      • Epilepsy Journalism Award
        • Nomination Form
        • Background Information
      • Epilepsy-Personal Stories
        • Hanna, Germany
        • Judith, The Netherlands
        • Catherine, United Kingdom
        • Michael, Austria
        • Andrea, Switzerland
        • Marion, France
        • Laurens, The Netherlands
        • Monica, The Netherlands
        • Alexander, The Netherlands
        • Anja, Germany
        • Dominic, United Kingdom
      • Useful information
        • Epilepsy Professional Organisations
        • Epilepsy Patient Groups
      • Epilepsy Conference Dates
        • Key Epilepsy Congresses 2008
        • Epilepsy Awareness Days
      • Press request
    • Asthma Media Centre
      • Asthma resources
        • Asthma fact sheets
        • Asthma glossary
      • News flashes from the World Congress of Asthma
      • Asthma insights
        • Professor Leonardo M. Fabbri
        • Professor Arzu Yorgancioğlu
        • Professor Mina Gaga
        • Professor Ronald Dahl
      • Asthma image library
      • Media e-alerts
      • Press Request
  • UCB Archive
  • Schwarz Pharma Archive